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Dear Editor,
We read with great interest the article ‘‘Percutaneous
closure of a post-traumatic ventricular septal defect with a
patent ductus arteriosus occluder’’ written by Xi EP et al.
(1). The authors aimed to report their experiences with three
patients who underwent the percutaneous closure of a post-
traumatic ventricular septal defect (VSD) with a patent
ductus arteriosus (PDA) occluder. They concluded that the
closure of a post-traumatic ventricular septal defect using a
PDA occluder is feasible, safe, and effective. We believe that
these findings will act as a guide for further studies
regarding the closure of post-traumatic ventricular septal
defects with occluder devices. We wish to make a minor
criticism about this study.
In the first case, the authors placed a muscular VSD
occluder. However, its right plate had an inappropriate
configuration; thus, they closed the defect with a PDA
occluder. Therefore, they selected the PDA occluder in the
two subsequent patients. Although the percutaneous clo-
sure of traumatic and postinfarction VSDs can be accom-
plished with septal occluder devices safely and effectively
(2,3), why did they choose the PDA occluder for the other
two patients? Additionally, why did they not try to implant
a VSD occluder device? In the Discussion section, they
indicated that the PDA occluder cannot cause a ventricular
outflow tract obstruction. However, all of the patients had
muscular VSD, which itself cannot occlude the outflow tract.
The percutaneous therapy of structural heart defects has
become an alternative approach to surgery in selected
patients. The most important considerations before per-
forming the percutaneous closure are whether the defect can
be closed via the percutaneous approach and which device
should be selected. There has generally been no consensus
on the selection of the device. Further studies should be
conducted in the development of defect-specific devices,
which may result in an improvement in patient outcome.
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